MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Net Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹1,322 Cr | ₹4,446 Cr | ₹2,461 Cr | ₹1,780 Cr | ₹2,526 Cr |
What is the latest Net Current Assets ratio of MANKIND PHARMA ?
Year | Net Current Assets |
---|---|
Mar2025 | ₹1,322 Cr |
Mar2024 | ₹4,446 Cr |
Mar2023 | ₹2,461 Cr |
Mar2022 | ₹1,780 Cr |
Mar2021 | ₹2,526 Cr |
How is Net Current Assets of MANKIND PHARMA Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹1,322 Cr | -70.26 | |
Mar2024 | ₹4,446 Cr | 80.62 | |
Mar2023 | ₹2,461 Cr | 38.25 | |
Mar2022 | ₹1,780 Cr | -29.52 | |
Mar2021 | ₹2,526 Cr | - |
Compare Net Current Assets of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹102,302.2 Cr | 1.5% | -3.5% | -10.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,872.0 Cr | 0.6% | 3.6% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,706.0 Cr | 1% | 9.4% | 8% | Stock Analytics | |
CIPLA | ₹127,449.0 Cr | 0.9% | 1.2% | -0.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,125.0 Cr | 1.7% | 1% | 1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,827.0 Cr | -0.5% | -4.2% | -6.3% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 1.5% |
-3.5% |
-10.6% |
SENSEX | 1.8% |
1.9% |
2.4% |
You may also like the below Video Courses